Correcting Hyperkalemia in CKD: Examining Current and Emerging Treatment Options
ISN Academy. Roger S. 04/24/19; 272232 Topic: Chronic kidney disease
Simon Roger
Simon Roger
Login now to access Regular content available to all registered users.

You may also access ISN content "anytime, anywhere" with the FREE ISN Academy App for iOS and Android.
Learning Objectives
Discussion Forum (0)
Rate & Comment (0)
Treatment options for hyperkalemia have been essentially unchanged since the 1960s, when the cation exchange resin, sodium polystyrene sulfonate (Kayexalate) was introduced. This session will provide a brief discussion of the traditional treatment interventions used for chronic hyperkalemia, such as dietary restriction, changes in medications, treatment of exacerbating metabolic abnormalities and sodium polystyrene sulfonate (Kayexalate), followed by a review of newer treatment options. The emergence of new oral potassium binders has resulted in the re-examination of therapeutic paradigms for chronic hyperkalemia management. The efficacy and safety of new potassium binders (e.g. patiromer and zirconium cyclosilicate) for chronic management of hyperkalemia was tested and proven in several randomized controlled clinical trials, which have also showed that it is possible to maintain RAASi therapy over extended periods of time while avoiding the re-emergence of hyperkalemia. The introduction of safe and effective long-term hyperkalemia treatment options addresses the previous limitations on RAASi utilization leading to improved optimization of patient care.
Expected Learning Outcomes:
Following are learning outcomes expected from the audience at the conclusion of this symposium.
  • Emphasis will be placed on these learning objectives and changes in practice. Examine the prevalence of and risk factors for hyperkalemia and its associated prognosis across healthcare settings
  • Appraise the recent shifts in treatment patterns that have occurred in the management of anemia in CKD
  • Describe commonly applied therapies for anemia and hyperkalemia and understand their advantages and disadvantages.
  • Become familiar with novel treatments for hyperkalemia and anemia, and their role in changing therapeutic paradigms optimizing management.
Code of conduct/disclaimer available in General Terms & Conditions

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies